These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31144792)

  • 1. Correlations of myocardial hypertrophy with inflammatory factors, vascular endothelial function and serum phosphorus concentration in uremia patients.
    Liu Y; Kong F; Zhao W
    Panminerva Med; 2020 Sep; 62(3):177-180. PubMed ID: 31144792
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of the relationship between remodeling of left ventricle and endothelial injury and pro-inflammatory mediators in different stages of essential hypertension].
    Cai JY; Zhai GL; Gao W; Zhu L; Li Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Dec; 20(12):743-5. PubMed ID: 19111125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of endothelin-1 and nitric oxide on left ventricular remodelling in patients on peritoneal dialysis.
    Rebic D; Rasic S; Rebic V
    Ren Fail; 2014 Mar; 36(2):232-6. PubMed ID: 24059246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between endothelial dysfunction and left ventricular remodeling in patients with chronic kidney disease.
    Peng T; Hu Z; Wu L; Li D; Yang X
    Kidney Blood Press Res; 2014; 39(5):420-6. PubMed ID: 25412643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
    Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
    Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunologic disorders and dysfunction of endothelium as predictors of development of hypertrophy of left ventricle of heart in patients with hypertension disease].
    Aksenova TA
    Klin Lab Diagn; 2013 Aug; (8):18-20. PubMed ID: 24340743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.
    Chess DJ; Khairallah RJ; O'Shea KM; Xu W; Stanley WC
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1585-93. PubMed ID: 19767529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating biomarkers of left ventricular hypertrophy in pediatric coarctation of the aorta.
    Frank BS; Urban TT; Lewis K; Tong S; Cassidy C; Mitchell MB; Nichols CS; Davidson JA
    Congenit Heart Dis; 2019 May; 14(3):446-453. PubMed ID: 30650250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lower extremity revascularization on the endothelial functions measured with noninvasive brachial artery flow-mediated dilatation.
    Unal O; Karatepe O; Ugurlucan M; Koc B; Filizcan U; Aksoy M
    Ann Vasc Surg; 2011 Oct; 25(7):969-74. PubMed ID: 21530156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iptakalim: a new or just another KCO?
    Costa AD
    Cardiovasc Res; 2009 Aug; 83(3):417-8. PubMed ID: 19515796
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study.
    Ayus JC; Mizani MR; Achinger SG; Thadhani R; Go AS; Lee S
    J Am Soc Nephrol; 2005 Sep; 16(9):2778-88. PubMed ID: 16033855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study.
    Jekell A; Malmqvist K; Wallén NH; Mörtsell D; Kahan T
    J Cardiovasc Pharmacol; 2013 Dec; 62(6):559-66. PubMed ID: 24084214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
    Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
    Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
    Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
    Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
    Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.